INVO Fertility (IVF) Total Debt (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.02% |
| Jun 30, 2025 | -0.73% |
| Mar 31, 2025 | 67.72% |
| Dec 31, 2024 | -0.16% |
| Sep 30, 2024 | -1.05% |
| Jun 30, 2024 | -1.09% |
| Mar 31, 2024 | -1.08% |
| Dec 31, 2023 | 242.83% |
| Sep 30, 2021 | 36.25% |
| Jun 30, 2021 | 34.77% |
| Mar 31, 2021 | -65.40% |
| Dec 31, 2019 | 17.90% |
| Sep 30, 2019 | 21.80% |
| Jun 30, 2019 | 60.83% |
| Mar 31, 2019 | 37.34% |
| Dec 31, 2018 | 61.75% |
| Sep 30, 2018 | -95.73% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | -42.27% |
| Dec 31, 2017 | 48.55% |
| Sep 30, 2017 | 16.62% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | -14.25% |
| Dec 31, 2016 | 16.62% |
| Sep 30, 2013 | 96.08% |
| Jun 30, 2013 | -42.11% |
| Mar 31, 2013 | 250.77% |
| Dec 31, 2012 | -76.28% |
| Sep 30, 2012 | 119.47% |
| Jun 30, 2012 | -30.83% |
| Mar 31, 2012 | 23.85% |
| Dec 31, 2011 | -33.26% |
| Sep 30, 2011 | -49.62% |